Inventor · disambiguated record
Sydney Welt
Also filed as: WELT SYDNEY
19 granted patents·3 pending applications·590 citations·filing 1991–2018
96Inventor score
Files withLUDWIG INST CANCER RES10SLOAN KETTERING INST CANCER7WELT BIO MOLECULAR PHARMACEUTLICAL LLC2WELT SYDNEY1
Top patents by PatentIndex Score
22 records- 0193US6310185B1Recombinant human anti-Lewis Y antibodiesSLOAN KETTERING INST CANCER·Filed 1994·Granted Oct 30, 2001·112 cites·6 claims
- 0289US6342587B1A33 antigen specific immunoglobulin products and uses thereofLUDWIG INST CANCER RES·Filed 1999·Granted Jan 29, 2002·93 cites·15 claims
- 0387US6652853B2Method for treating cancer using A33 specific antibodies and chemotherapeutic agentsLUDWIG INST CANCER RES·Filed 2001·Granted Nov 25, 2003·28 cites·28 claims
- 0487US6346249B1Methods for reducing the effects of cancers that express A33 antigen using A33 antigen specific immunoglobulin productsLUDWIG INST CANCER RES·Filed 2000·Granted Feb 12, 2002·13 cites·19 claims
- 0587US5874060ARecombinant human anti-Lewis Y antibodiesSLOAN KETTERING INST CANCER·Filed 1997·Granted Feb 23, 1999·49 cites·7 claims
- 0685US5712369AIsolated protein which binds to A33 antibody, and peptides corresponding to portions of the proteinLUDWIG INST CANCER RES·Filed 1996·Granted Jan 27, 1998·63 cites·7 claims
- 0782US5160723AMethod of imaging colorectal carcinoma lesion and composition for use thereinSLOAN KETTERING INST CANCER·Filed 1991·Granted Nov 3, 1992·55 cites·8 claims
- 0875US5851526AMethods of treating colon cancer utilizing tumor-specific antibodiesLUDWIG INST CANCER RES·Filed 1995·Granted Dec 22, 1998·36 cites·11 claims
- 0974US6291235B1Isolated nucleic acid which encodes protein which binds to A33 antibodyLUDWIG INST CANCER RES·Filed 1996·Granted Sep 18, 2001·24 cites·6 claims
- 1072US9926381B2Antibodies targeting B-cell receptor complex membrane bound IGM and uses thereofWELT BIO MOLECULAR PHARMACEUTLICAL LLC·Filed 2014·Granted Mar 27, 2018·5 cites·12 claims
- 1172US6190640B1Method for treating neoplasia using humanized antibodies which bind to antigen A33LUDWIG INST CANCER RES·Filed 1996·Granted Feb 20, 2001·25 cites·6 claims
- 1268US5431897AMethod of imaging colorectal carcinoma lesion and composition for use thereinSLOAN KETTERING INST CANCER·Filed 1993·Granted Jul 11, 1995·26 cites·12 claims
- 1367US5958412AMethods of treating colon cancer utilizing tumor-specific antibodiesLUDWIG INST CANCER RES·Filed 1997·Granted Sep 28, 1999·24 cites·5 claims
- 1465US6518415B1Recombinant human anti-Lewis Y antibodiesLUDWIG INST CANCER RES·Filed 1997·Granted Feb 11, 2003·11 cites·24 claims
- 1562US5795961ARecombinant human anti-Lewis b antibodiesLUDWIG INST CANCER RES·Filed 1995·Granted Aug 18, 1998·12 cites·5 claims
- 1648US2003031671A1Methods of treating colon cancer utilizing tumor-specific antibodiesFiled 2001·Application pending·0 cites
- 1747US6025481AIsolated nucleic acid molecules which encode human anti-Lewis b antibodiesSLOAN KETTERING INST CANCER·Filed 1998·Granted Feb 15, 2000·4 cites·12 claims
- 1847US5643550AMethod of treating colorectal carcinoma lesion and composition for use thereinSLOAN KETTERING INST CANCER·Filed 1994·Granted Jul 1, 1997·9 cites·5 claims
- 1945US10227419B2Antibodies targeting B-cell receptor complex membrane bound IgM and uses thereofWELT BIO MOLECULAR PHARMACEUTLICAL LLC·Filed 2018·Granted Mar 12, 2019·0 cites·7 claims
- 2043US2003040027A1Method for determining protein component in a biological sampleFiled 2002·Application pending·0 cites
- 2139US2009220416A1Immunoglobulin associated cell-surface determinants in the treatment of b-cell disordersWELT SYDNEY·Filed 2007·Application pending·0 cites
- 2229US5565356AHybridoma cell lines which produce monoclonal antibodies having the properties of monoclonal antibody 100-310 and the monoclonal antibodies produced by these hybridoma cell linesSLOAN KETTERING INST CANCER·Filed 1994·Granted Oct 15, 1996·1 cites·2 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →